Evidence map›Paper›PMID 31496752›Full record

ReviewJournal of asthma and allergy2019

NSAID-induced reactions: classification, prevalence, impact, and management strategies.

Natalia Blanca-Lopez, Victor Soriano, Elena Garcia-Martin, Gabriela Canto, Miguel Blanca

Open access · goldAbstract readReview
In one paragraph

Review in Journal of asthma and allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Article
  11. Anaphylactic shock due to mefenamic acid.Indian journal of pharmacology · 2025
    Article
  12. Allergy to acetylsalicylic acid among patients with acute coronary syndrome.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Article
  13. Article
  14. Article
  15. Recognizing Kounis Syndrome, the Unusual Possible Culprit of Acute Coronary Syndrome: A Rare Case Report.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Natalia Blanca-LopezInfanta Leonor University Hospital , Madrid, Spain.
Victor SorianoGeneral University Hospital of Alicante-ISABIAL , Alicante, Madrid, Spain.
Elena Garcia-MartinMedical and Surgery Therapy Department, University of Extremadura, Caceres, Spain.
Gabriela CantoInfanta Leonor University Hospital , Madrid, Spain.
Miguel BlancaInfanta Leonor University Hospital , Madrid, Spain.
Hospital Universitario Infanta Leonor · ESHospital General Universitario de Alicante Doctor Balmis · ESUniversidad de Extremadura · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the leading cause of hypersensitivity drug reactions. The different chemical structures, cyclooxygenase 1 (COX-1) and/or COX-2 inhibitors, are taken at all ages and some can be easily obtained over the counter. Vasoactive inflammatory mediators like histamine and leukotriene metabolites can produce local/systemic effects. Responders can be selective (SR), IgE or T-cell mediated, or cross-intolerant (CI). Inhibition of the COX pathway is the common mechanism in CI, with the skin being the most frequent organ involved, followed by the lung and/or the nose. An important number of cases have skin and respiratory involvement, with systemic manifestations ranging from mild to severe anaphylaxis. Among SR, this is the most frequent entity, often being severe. Recent years have seen an increase in reactions involving the skin, with many cases having urticaria and/or angioedema in the absence of chronic urticaria. Aspirin, the classical drug involved, has now been replaced by other NSAIDs, with ibuprofen being the universal culprit. For CI, no in vivo/in vitro diagnostic methods exist and controlled administration is the only option unless the cases evaluated report repetitive and consistent episodes with different NSAIDs. In SR, skin testing (patch and intradermal) with 24-48 reading can be useful, mainly for delayed T-cell responses. Acetyl salicylic acid (ASA) is the test drug to establish the diagnosis and confirm/exclude CI by controlled administration. Desensitization to ASA has been extensively used in respiratory cases though it can also be applied in those cases where it is required.

Indexed as

hypersensitivity drug reactionsmanagementmechanismsNSAIDs

Identifiers

PMID31496752
PMCPMC6690438
OpenAlexW2965880536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.